Bad Haircuts: 2005's Biotech IPOs--Getting Out at Any Price?
This article was originally published in Start Up
Executive Summary
The haircuts suffered by 2005's biotech IPOs are further proof that while the appetite for biotech offerings exists, public investors are demanding a better likelihood of post-market upside.